Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland26 enrolled

Overview

The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care \& community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV Infection Pregnancy

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pregnant Women * HIV-positive * Antiretroviral medication delivered in electronical monitors Exclusion Criteria: * Monitored period during pregnancy \< 1 month

Locations (1)

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, Switzerland

Outcomes

Primary Outcomes

Change in patient adherence during pregnancy and postpartum

By electronic drug monitoring, pill count and subject interviews' marks

Time frame: before delivery (1 to 9 month) and postpartum (6 month)

Secondary Outcomes

Adherence barriers and facilitators

Data recorded in subject's interview marks

Time frame: pregnancy and postpartum (6 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.